Diabetes

News

Promising revolution, Intarcia's diabetes device poised for ...

Intarcia Therapeutics is primed to file its potentially revolutionary diabetes drug delivery device after revealing positive cardiovascular safety results.

Sales & Marketing

New drugs boost Lilly in Q1 as company hopes for turnaround ...

New drugs from Eli Lilly have produced a strong showing in the first quarter, in what could be a key year for a company still recovering from patent expiry of its former blockbuster antidep

News

Boehringer Ingelheim, Biberach, Germany, February 2007

Diabetes drugs help Boehringer Ingelheim to grow

Boehringer Ingelheim has posted a 4.1% rise in 2015 currency-adjusted sales, mainly thanks to a rapid acceleration in its diabetes drug revenues.

News

Novo Nordisk buoyed by Victoza cardiovascular results

Largest and longest trial ever conducted by the company

News

First-in-class diabetes drug recommended for FDA approval

AstraZeneca and Bristol-Myers Squibb have received a positive opinion from an FDA committee for dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor developed through an allian

News

Merck and Pfizer to collaborate on diabetes drug

Multimillion-dollar diabetes collaboration between two leading pharma players. A global collaboration has been formed on phase III-ready diabetes drug ertugliflozin between Pfizer and Merck.

Promising revolution, Intarcia's diabetes device poised for ...

New drugs boost Lilly in Q1 as company hopes for turnaround ...

Diabetes drugs help Boehringer Ingelheim to grow

Novo Nordisk buoyed by Victoza cardiovascular results

First-in-class diabetes drug recommended for FDA approval

Merck and Pfizer to collaborate on diabetes drug

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

Diabetes

Editor's Picks